LVJIkM^lltMC
CHEMISTRY Aggressive deadlines. technology transfers.
Challenging Regulatory
chemistry. Complex compliance.
Why take chances w i t h the synthesis or manufacture of your preclinical candidates, clinical trial ingredients and APIs? The stakes are h i g h — a n d so is the risk w h e n working w i t h others. Albany Molecular Research, Inc. (AMRI) is a tested and proven partner, backed by years of successful collaborations, customer audits and FDA inspections. Over 400 scientists devoted t o solving even the most challenging problems. More than $125 million in recent facility and equipment upgrades. On-site analytical support, including m e t h o d development, structure elucidation, and physical characterization. And unmatched productivity, communication and customer satisfaction. There are better things t o gamble o n . Choose a partner that has experience, and the right combination of tools, technologies and k n o w - h o w for your project.
From drug discovery t o manufacturing, we can provide the competitive edge, Discovery: Lead-generation technologies, supported by world-class lead optimization. Development: A full range of chemical and bioprocess research, scale-up and development expertise. Analytical: Cutting-edge equipment and broad technologies, from chromatography and spectroscopy,to stability and physical chemistry studies. Manufacturing: cGMP synthesis capabilities, from clinical trial APIs to commercial bulk actives, including controlled substances and high potency.
Speed. Quality. Reliability. Experience. By any metric, w o r k i n g w i t h AMRI is a w i n n i n g scenario.
Albany Molecular Research, Inc.
21 Corporate Circle, PO Box 15098 Albany, NY 12212-5098 Phone:518-464-0279 · Fax:518-464-0289 www.albmolecular.com ·
[email protected]
